Veeprho reference standards
Reference standards published in the Veeprho catalogue, listed with CAS number, molecular formula, molecular weight and structure where available.
10,647 products · 178 pages
Veeprho products
-
Di-C-Nitroso Derivatives Of Propyl Gallate
IN STOCKRS-U204IOR -
Di-Nitroso-Pyrrolopiperidine (DNPP)
IN STOCKRS-U204IOS -
Revefenacin N,N-Dioxide
BACK ORDERRS-U205IPZ -
CPHI 프랑크푸르트 2025: 제약 혁신의 최전선 2025년 10월
BACK ORDERRS-U206IQA -
ICP-OES와 ICP-MS의 차이점
CUSTOM SYNTHESISRS-U206IQB -
HPLC와 GC 기술의 차이점
BACK ORDERRS-U206IQC -
HPLC를 통한 약물 불순물 반응 인자 측정
BACK ORDERRS-U206IQD -
NDSRI에 대한 대체 허용 섭취량을 결정하기 위한 적합한 대리 선택을 위한 전산 접근법
BACK ORDERRS-U206IQE -
21 CFR Part 11 규정 준수에 대한 종합 가이드
BACK ORDERRS-U206IQF -
의약품 내 DNA 반응성(변이원성) 불순물의 M7(R2) 평가 및 관리에 대한 FDA 지침
BACK ORDERRS-U206IQG -
AQbD(분석 품질 설계)
CUSTOM SYNTHESISRS-U206IQH -
505(j), 505(b)(1) 및 505(b)(2)의 차이점을 이해하십시오.
BACK ORDERRS-U206IQJ -
ICH M7 지침에따른잠재적돌연변이불순물분류이해
CUSTOM SYNTHESISRS-U206IQK -
FDA 및 EDQM 2024의규제업데이트
BACK ORDERRS-U206IQL -
HPLC 분석테스트: HPLC 분석테스트란무엇이며왜중요한가
BACK ORDERRS-U206IQN -
최근 FDA가유전독성불순물이월관련경고서를발표했습니다.
BACK ORDERRS-U206IQO -
cGMP의 10가지원칙
BACK ORDERRS-U206IQQ -
니트로사민약물물질관련불순물에대한 AI 한도에대한업계용 FDA 지침
CUSTOM SYNTHESISRS-U206IQS -
Q3 반고형 제형의 특성 분석
BACK ORDERRS-U206IQU -
ICH M9와 ICH M13B: 목표는 같으나 사고 과정은 다르다
BACK ORDERRS-U206IQV -
Posouzení rizika pro nečistoty Nitrosaminu
BACK ORDERRS-U206IQW -
Master Safety Data Sheet
BACK ORDERRS-U206IQX -
USP 일반 장 <41> 및 <1251> '올바른 칭량 관행(Good Weighing Practices)' 개요
BACK ORDERRS-U206IQY -
Out of Specification due to Impurities: Investigation Strategy
BACK ORDERRS-U206IQZ -
Nitrosamine Control in APIs & Drug Products: Where Most Companies Still Fail
CUSTOM SYNTHESISRS-U206IR0 -
LC-MS in GMP QC Lab
BACK ORDERRS-U206IR1 -
Power of Sonication in Pharma Industry
BACK ORDERRS-U206IR2 -
Mass Spectrometry
BACK ORDERRS-U206IR3 -
An Overview of Preclinical and Clinical Study
BACK ORDERRS-U206IR4 -
Pharmaceutical Packaging Material
BACK ORDERRS-U206IR5 -
Process of Setting up Pharmaceutical Specifications
BACK ORDERRS-U206IR6 -
Laboratory Quality Testing: Best Practices & Compliance
BACK ORDERRS-U206IR8 -
Liquid-Liquid Extraction (LLE) & Supported-Liquid Extraction (SLE)
CUSTOM SYNTHESISRS-U206IR9 -
Nitrosamine Current Challenges and Way Forward
BACK ORDERRS-U206IRA -
Navigating Quality Control in Clinical Trials for Reliable Results
BACK ORDERRS-U206IRB -
SUPAC Guidelines
CUSTOM SYNTHESISRS-U206IRC -
NDSRI에 대한 허용 섭취량(AI): FDA, EMA 및 캐나다 보건부 비교
CUSTOM SYNTHESISRS-U206IRD -
Navigating the Nimesulide Landscape: Impurities, Efficacy, and Regulatory Status
BACK ORDERRS-U206IRF -
Pharmacopeial Standards: Ensuring Quality and Safety in Healthcare
BACK ORDERRS-U206IRG -
Metronidazole: Drug Information
BACK ORDERRS-U206IRH -
Patenting in the Indian Pharmaceutical Industry
BACK ORDERRS-U206IRI -
Peptides and Probable Degradation Pathways
BACK ORDERRS-U206IRJ -
Overview & Determination of Enantiomeric Impurities
BACK ORDERRS-U206IRK -
Overview of Degradation Products
BACK ORDERRS-U206IRL -
Polymorphic Impurities: Risk Assessment & Investigation
CUSTOM SYNTHESISRS-U206IRM -
Privacy Policy
CUSTOM SYNTHESISRS-U206IRN -
CEP 신청 결함
BACK ORDERRS-U206IRQ -
Impurity Price List
BACK ORDERRS-U206IRR -
-and Related Compound
BACK ORDERRS-U206IRS -
Diethyl 2-(((3-chlorophenyl)(nitroso) amino)methylene)malonate
CUSTOM SYNTHESISRS-U204IV4 -
Dimer of Ampicilloic Acids
BACK ORDERRS-U204IV5 -
Dihydro Abamectin A1a Impuirty 3
BACK ORDERRS-U204IV6 -
(DL-Phenylglycyl)-piperacilloic Acid
CUSTOM SYNTHESISRS-U204IV7 -
Diclofenac glyoxilic acid
IN STOCKRS-U204IV8 -
Diclofenac PPG Ester (Mixture PPG 1 & PPG 2)
IN STOCKRS-U204IV9 -
Diclofenac Tetradecyl ester
BACK ORDERRS-U204IVA -
Diclofenac Glyceryl Adduct
CUSTOM SYNTHESISRS-U204IVB -
Dolutegravir Propyl Analouge
BACK ORDERRS-U204IVC
10,647 products · 178 pages